Last Posted: Dec 14, 2018
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
N Mavaddat et al, AJHG, December 13, 2018 - The Warwick Experience of the Oncotype DX® Breast Recurrence Score® Assay as a Predictor of Chemotherapy Administration.
Khan Mashuk Alam et al. Breast care (Basel, Switzerland) 2018 Oct 13(5) 369-372 - Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
PD Beitsch et al, JCO, December 10, 2018 - A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg Talia et al. Breast cancer research and treatment 2018 Dec - Cancer Research Driven by Patients and Technology.
et al. Cancer discovery 2018 Dec - Gene panel testing for breast cancer should not be used to confirm syndromic gene associations.
Evans D Gareth et al. NPJ genomic medicine 2018 332 - Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer.
Breaux Andrea et al. Clinical breast cancer 2018 Oct - Breast cancer testing guidelines out of date, missing genetic screening, says study
S Scutti, CNN, December 10, 2018 - A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study.
Nunziato Marcella et al. Analytica chimica acta 2019 Jan 1046154-162 - A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults
M. Murray and the Genomics and Population Health Action Collaborative, National Academies of Medicine, December 3, 2018
.png)
No hay comentarios:
Publicar un comentario